Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Treton

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|September 5, 2024
Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: The ERIC studyNathan Grellier, Julien Kirchgesner, Mathieu Uzzan, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agentAnthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS studyAnthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
Molecular Pharmaceutics|July 8, 2010
Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first passArnaud Bruyère, Xavier Declèves, Francois Bouzom, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2018
Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative ColitisIan Morilla, Mathieu Uzzan, David Laharie, et al.
Lancet (London, England)|August 27, 2013
Intestinal failure after bariatric surgeryOlivier Corcos, Dominique Cazals-Hatem, François Durand, et al.
Gut|May 31, 2019
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's diseaseHarry Sokol, Loic Brot, Carmen Stefanescu, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 5, 2020
Long-term efficacy of fibrin glue injection for perianal fistulas in patients with Crohn's diseaseMathias Vidon, Nicolas Munoz-Bongrand, Jérôme Lambert, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort studyClaire Auzolle, Stephane Nancey, My-Linh Tran-Minh, et al.
Oncogene|September 6, 2022
Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiologyEmeric Boisteau, Céline Posseme, Federico Di Modugno, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|September 5, 2024
Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: The ERIC studyNathan Grellier, Julien Kirchgesner, Mathieu Uzzan, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agentAnthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS studyAnthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
Molecular Pharmaceutics|July 8, 2010
Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first passArnaud Bruyère, Xavier Declèves, Francois Bouzom, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2018
Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative ColitisIan Morilla, Mathieu Uzzan, David Laharie, et al.
Lancet (London, England)|August 27, 2013
Intestinal failure after bariatric surgeryOlivier Corcos, Dominique Cazals-Hatem, François Durand, et al.
Gut|May 31, 2019
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's diseaseHarry Sokol, Loic Brot, Carmen Stefanescu, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 5, 2020
Long-term efficacy of fibrin glue injection for perianal fistulas in patients with Crohn's diseaseMathias Vidon, Nicolas Munoz-Bongrand, Jérôme Lambert, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort studyClaire Auzolle, Stephane Nancey, My-Linh Tran-Minh, et al.
Oncogene|September 6, 2022
Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiologyEmeric Boisteau, Céline Posseme, Federico Di Modugno, et al.
Pageof 7